BE826568A - Procede de preparation de vaccins vivants contre la varicelle - Google Patents

Procede de preparation de vaccins vivants contre la varicelle

Info

Publication number
BE826568A
BE826568A BE2054201A BE2054201A BE826568A BE 826568 A BE826568 A BE 826568A BE 2054201 A BE2054201 A BE 2054201A BE 2054201 A BE2054201 A BE 2054201A BE 826568 A BE826568 A BE 826568A
Authority
BE
Belgium
Prior art keywords
vaccines against
live vaccines
preparing live
against chickenpox
chickenpox
Prior art date
Application number
BE2054201A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE826568A publication Critical patent/BE826568A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE2054201A 1974-03-12 1975-03-12 Procede de preparation de vaccins vivants contre la varicelle BE826568A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2931874A JPS5341202B2 (fr) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
BE826568A true BE826568A (fr) 1975-09-12

Family

ID=12272859

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2054201A BE826568A (fr) 1974-03-12 1975-03-12 Procede de preparation de vaccins vivants contre la varicelle

Country Status (5)

Country Link
US (1) US3985615A (fr)
JP (1) JPS5341202B2 (fr)
BE (1) BE826568A (fr)
FR (1) FR2263786B1 (fr)
GB (1) GB1457382A (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077590A (en) * 1980-01-25 1981-12-23 Wistar Inst Highly attenuated varicella virus vaccine and production thereof
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
NZ220645A (en) * 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
IL86180A (en) * 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
UA27137C2 (uk) * 1992-06-04 2000-02-28 Мерк Енд Ко., Інк. Спосіб одержаhhя вакциhи hа осhові живого атеhуйов
CA2139515C (fr) 1992-07-17 2008-12-23 Gary B. Calandra Methode de prevention du zona ou de soulagement des algies post-zosteriennes associees a la varicelle
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
US6093535A (en) * 1996-05-15 2000-07-25 The Research Foundation For Microbial Diseases Of Osaka University Method for identifying attenuated chickenpox virus Oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
GB9804632D0 (en) 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
WO2000050603A1 (fr) * 1999-02-25 2000-08-31 The Research Foundation For Microbial Diseases Of Osaka University Gene 62 de la souche oka du virus de la varicelle attenue et procede d'identification de la souche du virus pour le vaccin de la varicelle vivant attenue a l'aide de ce gene
US6528066B1 (en) 1999-09-14 2003-03-04 University Of Iowa Research Foundation Variant varicella-zoster viruses and methods of use
AU2003295398A1 (en) * 2002-11-05 2004-06-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Safer attenuated virus vaccines with missing or diminished latency of infection
US8916175B2 (en) * 2004-06-29 2014-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
US10166285B2 (en) 2006-11-09 2019-01-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Recombinant virus with diminished latency and methods of using same
EP2095826B1 (fr) 2006-11-17 2012-12-26 The Research Foundation for Microbial Diseases of Osaka University Agent promoteur de l'etirement des nerfs et agent inhibiteur de l'etirement des nerfs
CN101967466A (zh) 2009-07-28 2011-02-09 新泽西医学院 Orf7缺陷型水痘病毒株、含有该毒株的疫苗及其应用
UA112970C2 (uk) 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
EP2686423A4 (fr) 2011-03-14 2015-01-28 Nat Res Council Canada Procédé de production virale dans des cellules
US10232035B2 (en) 2012-09-14 2019-03-19 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes virus and use thereof in vaccines
SG11201803594TA (en) 2015-11-06 2018-05-30 Adjuvance Technologies Inc Triterpene saponin analogues

Also Published As

Publication number Publication date
JPS50123817A (fr) 1975-09-29
US3985615A (en) 1976-10-12
FR2263786A1 (fr) 1975-10-10
GB1457382A (en) 1976-12-01
JPS5341202B2 (fr) 1978-11-01
FR2263786B1 (fr) 1978-12-01

Similar Documents

Publication Publication Date Title
BE826568A (fr) Procede de preparation de vaccins vivants contre la varicelle
BE805207A (fr) Procede de preparation de compositions aromatisantes
BE797300A (fr) Procede de preparation de vaccins adsorbes
BE858992A (fr) Procede de preparation de vaccins
BE823677A (fr) Procede de preparation de thiophosphates de dialkyle
FR2335235A1 (fr) Procede de preparation de substances anti-tumorales
FR2295138A1 (fr) Procede de preparation de bis-acetals de p-benzoquinones
FR2277804A1 (fr) Procede de preparation de polyalcools et de leurs ethers et esters
BE813169A (fr) Procede de preparation des 3-fluorocephalosporines
FR2282429A1 (fr) Procede de preparation de 7b-acylamino-7a-alcoxycephalosporines
BE824612A (fr) Procede de preparation de 3-aminophenols
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
BE807056A (fr) Procede de preparation de dialkylphosphines
FR2284608A1 (fr) Procede de preparation de la cefazoline
BE763141A (fr) Procede de preparation de dichloropropanols
FR2289536A1 (fr) Procede de preparation de c
BE831786A (fr) Vaccin contre la gravidite et procede de sa preparation
BE801697A (fr) Procede de preparation des benzyl-monocetals
BE772448A (fr) Procede de preparation d'un vaccin vivant contre la bursite infectieusedes poules
BE826237A (fr) Procede de preparation de bischlorocarbonates de bispheno
BE820739A (fr) Procede de preparation de monoesters phosphoriques aliphatiques
BE828230A (fr) Procede de preparation de trimethyl-p-benzoquinone
FR2333804A1 (fr) Procede de preparation de derives 3-methylenecepham
FR2292710A1 (fr) Procede de preparation de derives de 7a-methoxycephalosporines
BE821447A (fr) Procede de preparation de trimethyl-p-benzoquinone

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: RESEARCH FOUNDATION FOR NICROBIAL DISEASES OF OSA

Effective date: 19950312